Cheng CY, Hao WR, Cheng TH. Esophageal cancer: A global challenge requiring tailored strategies. World J Gastrointest Oncol 2024; 16(7): 2881-2883 [PMID: 39072159 DOI: 10.4251/wjgo.v16.i7.2881]
Corresponding Author of This Article
Tzu-Hurng Cheng, PhD, Professor, Department of Biochemistry, School of Medicine, College of Medicine, China Medical University, No. 91 Xueshi Road, North District, Taichung 404333, Taiwan. thcheng@mail.cmu.edu.tw
Research Domain of This Article
Medicine, General & Internal
Article-Type of This Article
Editorial
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Gastrointest Oncol. Jul 15, 2024; 16(7): 2881-2883 Published online Jul 15, 2024. doi: 10.4251/wjgo.v16.i7.2881
Esophageal cancer: A global challenge requiring tailored strategies
Chun-Yao Cheng, Wen-Rui Hao, Tzu-Hurng Cheng
Chun-Yao Cheng, Department of Medical Education, National Taiwan University Hospital, Taipei 100225, Taiwan
Wen-Rui Hao, Division of Cardiology, Department of Internal Medicine, Shuang Ho Hospital, Ministry of Health and Welfare, Taipei Medical University, New Taipei 23561, Taiwan
Wen-Rui Hao, Division of Cardiology, Department of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical University, Taipei 11002, Taiwan
Tzu-Hurng Cheng, Department of Biochemistry, School of Medicine, College of Medicine, China Medical University, Taichung 404333, Taiwan
Co-first authors: Chun-Yao Cheng and Wen-Rui Hao.
Author contributions: Cheng CY and Hao WH contributed equally; Cheng CY wrote the paper; Hao WH and Cheng TH revised the paper; All authors have read and approved the final manuscript.
Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Tzu-Hurng Cheng, PhD, Professor, Department of Biochemistry, School of Medicine, College of Medicine, China Medical University, No. 91 Xueshi Road, North District, Taichung 404333, Taiwan. thcheng@mail.cmu.edu.tw
Received: February 24, 2024 Revised: April 25, 2024 Accepted: May 14, 2024 Published online: July 15, 2024 Processing time: 138 Days and 17.3 Hours
Abstract
In this editorial we comment on the article published in a recent issue of the World Journal of Gastrointestinal Oncology. Characterized by high mortality rates and geographical variations in its incidence, esophageal cancer poses a major global health challenge. This editorial article synthesizes insights from the review of esophageal cancer conducted by Qu et al, which highlights the importance of tailored screening and treatment strategies. Key themes include the effect of regional disparities on screening protocols, advancements in early detection methodologies, and therapeutic management disparities between different regions. By embracing personalized approaches grounded in regional nuances and technological innovation, the article advocates for comprehensive and collaborative efforts to improve patient outcomes in esophageal cancer care.
Core Tip: Regional disparities and histological variations in esophageal cancer underscore the importance of tailored screening and treatment strategies. Customized screening protocols, advancements in imaging technologies, and integration of biomarkers are promising avenues for early detection and precision treatment. Embracing a multidisciplinary approach and technological innovations is crucial for improving outcomes in esophageal cancer management globally.
